Nyxoah (NYXH) Total Current Liabilities (2020 - 2026)
Nyxoah's (NYXH) quarterly Total Current Liabilities came in at $48.1 million in Q1 2026, up 117.89% year-on-year from $22.1 million in Q1 2025, and down 15.66% quarter-over-quarter from $57.0 million in Q4 2025.
Nyxoah (NYXH) Total Current Liabilities (2020 - 2026) Analysis & Trends
Nyxoah's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $48.1 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 117.89% year-over-year to $48.1 million in Q1 2026; TTM through Mar 2026 was $48.1 million, a 117.89% increase from a year earlier, with the FY2025 full-year figure at $57.0 million, up 147.72% from the prior year.
- Total Current Liabilities slipped to $48.1 million in Q1 2026 per NYXH's latest filing, from $57.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $20.2 billion in Q3 2022 and bottomed at $14.2 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $17.4 million (2024), against an average of $1.4 billion.
- Across the five-year window, Total Current Liabilities sank 99.92% in 2023 and soared 147.72% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $15.2 million in 2022, then grew by 2.14% to $15.5 million in 2023, then jumped by 48.04% to $23.0 million in 2024, then surged by 147.72% to $57.0 million in 2025, then slipped by 15.66% to $48.1 million in 2026.
- Per Business Quant, the three latest NYXH Total Current Liabilities figures stand at $48.1 million (Q1 2026), $57.0 million (Q4 2025), and $23.7 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Nyxoah | 56.02 Mn | 103.00 Mn | 4.26 Mn | 48.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.07 Mn |
| Dec 31, 2025 | 56.99 Mn |
| Jun 30, 2025 | 23.71 Mn |
| Mar 31, 2025 | 22.06 Mn |
| Dec 31, 2024 | 23.01 Mn |
| Sep 30, 2024 | 17.37 Mn |
| Jun 30, 2024 | 17.64 Mn |
| Mar 31, 2024 | 15.18 Mn |
| Dec 31, 2023 | 15.54 Mn |
| Sep 30, 2023 | 15.74 Mn |
| Jun 30, 2023 | 16.59 Mn |
| Mar 31, 2023 | 15.39 Mn |
| Dec 31, 2022 | 15.21 Mn |
| Sep 30, 2022 | 20.17 Bn |
| Mar 31, 2022 | 14.19 Mn |
| Dec 31, 2021 | 13.24 Mn |
| Dec 31, 2020 | 7.63 Mn |